What is the ReWalk 7 deployment at United States?

ReWalk 7, built by Lifeward, is recorded as a deployment at United States on the DEPLOY registry. Lifeward operates the deployment directly.

Who operates ReWalk 7 at United States?

Lifeward, the manufacturer of ReWalk 7, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.

Is the ReWalk 7 deployment at United States still active?

As of the most recent verification on the DEPLOY registry, this deployment is currently operating.

Have there been incidents at the ReWalk 7 deployment at United States?

No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deployment

ReWalk 7 at United States

Name: ReWalk 7 at United States
Location: United States

Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.

ReWalk 7 by Lifeward · Catalog entry · 2 sources · not yet field-verified

Track ReWalk 7 at United States

Machine-readable surfaces

Markdown mirror: /deployments/rewalk-7-united-states.md
JSON-LD: embedded in this page’s head
REST API: /v1/robots/766748ba-e7ce-4860-9603-2b77dde9e286
Data documentation: /data
Query this programmatically: Deploy MCP

ReWalk 7 (FDA cleared March 2025) is the latest generation personal exoskeleton for spinal-cord-injury users. Major reimbursement milestones in 2025-2026: UnitedHealthcare (Nov 2025), Humana (Dec 2025), and Aetna (Feb 2026) Medicare Advantage prior authorizations cover ~16M beneficiaries. CMS 2024 Home Health PPS Rule created lump-sum reimbursement pathway. June 2025 ALJ ruling established precedent that personal exoskeletons are 'reasonable and necessary.' Only FDA-cleared personal exoskeleton with stairs/curbs capability. Home use and clinical deployment across the US.

Key facts

FDA clearance: ReWalk 7 cleared March 2025
Medicare Advantage coverage: Aetna (Feb 2026), Humana (Dec 2025), UnitedHealthcare (Nov 2025) — ~16M beneficiaries total
CMS pathway: 2024 Medicare Home Health PPS Rule placed personal exoskeletons in brace benefit category, effective Jan 1 2024
ALJ precedent: June 2025: Administrative Law Judge ruled ReWalk 'reasonable and necessary' for Medicare beneficiary
Capability: Only personal exoskeleton cleared for stairs and curbs

Trust tier: Catalog entry · 2 sources · not yet field-verified
Last updated: 2026-06-07
Model: ReWalk 7
Company: Lifeward
Location: United States
Status: active
ID: 766748ba-e7ce-4860-9603-2b77dde9e286

Sources (2)

Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-06-07

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-06-07

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1: primary-company-ir; Company IR disclosure
1: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Common questions

What is the ReWalk 7 deployment at United States?: ReWalk 7, built by Lifeward, is recorded as a deployment at United States on the DEPLOY registry. Lifeward operates the deployment directly.
Who operates ReWalk 7 at United States?: Lifeward, the manufacturer of ReWalk 7, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
Is the ReWalk 7 deployment at United States still active?: As of the most recent verification on the DEPLOY registry, this deployment is currently operating.
Have there been incidents at the ReWalk 7 deployment at United States?: No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.